Published in Clin Pharmacol Ther on October 06, 2010
Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations. CPT Pharmacometrics Syst Pharmacol (2015) 0.94
The pharmacokinetic/pharmacodynamic pipeline: translating anticancer drug pharmacology to the clinic. AAPS J (2011) 0.91
Mechanism-based pharmacodynamic modeling. Methods Mol Biol (2012) 0.79
Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment. Eur J Clin Pharmacol (2016) 0.75
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial. J Thromb Haemost (2011) 2.87
Molecular cloning of a novel melanocortin receptor. J Biol Chem (1993) 1.89
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol (2002) 1.44
[IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia]. Dtsch Med Wochenschr (1992) 1.39
Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies. Curr Med Chem (2008) 1.32
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)". Onkologie (1987) 1.14
Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun (1991) 1.10
Methadone: a review of its pharmacokinetic/pharmacodynamic properties. J Pharmacol Toxicol Methods (1999) 1.08
Cerebral oxygenation changes in response to motor stimulation. J Appl Physiol (1985) (1996) 1.06
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. Int J Oncol (2001) 1.05
Rectocele: pathogenesis and surgical management. Int J Colorectal Dis (2003) 1.04
Molecular and electronic structure in NaCl electrolytes of varying concentration: identification of spectral fingerprints. J Chem Phys (2006) 1.00
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours. Curr Oncol (2012) 1.00
Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat. J Pharmacol Exp Ther (2001) 0.98
Molecular basis for the interaction of histamine with the histamine H2 receptor. J Biol Chem (1992) 0.98
Effects on the immune system. Handb Exp Pharmacol (2005) 0.97
Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities. Clin Pharmacol Ther (2014) 0.97
The SH2-containing adapter protein GRB10 interacts with BCR-ABL. Oncogene (1998) 0.97
Tomographical anatomy of the pelvis, pelvic floor, and related structures. Clin Anat (1997) 0.97
Intranuclear and cytoplasmic annulate lamellae in plant cells. J Cell Biol (1972) 0.96
Anatomical considerations regarding the "bare spot" of the glenoid cavity. Surg Radiol Anat (2004) 0.94
Vagally induced release of gastrin, somatostatin and bombesin-like immunoreactivity from perfused rat stomach. Effect of stimulation frequency and cholinergic mechanisms. Regul Pept (1990) 0.92
Cross-sectional imaging anatomy of the anal sphincters. Obstet Gynecol (1997) 0.92
Modeling the effect of propofol and remifentanil combinations for sedation-analgesia in endoscopic procedures using an Adaptive Neuro Fuzzy Inference System (ANFIS). Anesth Analg (2010) 0.91
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort. Eur J Med Res (2009) 0.91
A different kinetic profile of ochratoxin A in mature male rats. Food Chem Toxicol (2009) 0.91
Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats. J Pharmacol Exp Ther (1999) 0.90
Vascular considerations for stapled haemorrhoidopexy. Colorectal Dis (2009) 0.90
Cerebral oxygenation changes during motor and somatosensory stimulation in humans, as measured by near-infrared spectroscopy. Adv Exp Med Biol (1996) 0.86
Structural changes of the intravesical ureter in children with vesicoureteral reflux-does ischemia have a role? J Urol (2006) 0.86
Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats. J Pharmacol Exp Ther (2000) 0.85
Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. Int J Clin Pharmacol Ther (2000) 0.85
Population pharmacokinetic modelling and simulation of single and multiple dose administration of meloxicam in cats. J Vet Pharmacol Ther (2010) 0.84
Comparative pilot study of implantation techniques for pudendal neuromodulation: technical and clinical outcome in first 20 patients with chronic pelvic pain. World J Urol (2014) 0.84
Cartilage canals in the chicken embryo: ultrastructure and function. Anat Embryol (Berl) (2004) 0.83
Extracellular microenvironment and cytokine profile of the ureterovesical junction in children with vesicoureteral reflux. J Urol (2008) 0.82
Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats. J Pharmacol Exp Ther (2000) 0.82
[Stem cell therapy for urinary incontinence]. Urologe A (2004) 0.81
Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach. Br J Pharmacol (2007) 0.81
Fetal distribution of 5alpha-reductase 1 and 5alpha-reductase 2, and their input on human prostate development. J Urol (2007) 0.81
[Does osseous extensor tendon avulsion or rupture really exist? Histologic plastination studies of insertion of the extensor aponeurosis and significance for operative therapy]. Chirurg (1999) 0.81
Spatial and temporal dynamics of innervation during the development of fetal human pancreas. Neuroscience (2008) 0.80
Anatomic survey of the common fibular nerve and its branching pattern with regard to the intermuscular septa of the leg. Clin Anat (2004) 0.80
A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgery. Thromb Haemost (2012) 0.80
Pancreatic graft survival despite partial vascular graft thrombosis due to splenocephalic anastomoses. Am J Transplant (2010) 0.80
The development of the external urethral sphincter in humans. BJU Int (2001) 0.80
Effects of fasting and gender on ochratoxin A toxicokinetics in F344 rats. Food Chem Toxicol (2010) 0.80
Comparative pharmacokinetics, tissue distributions, and effects on renal function of novel polymeric formulations of amphotericin B and amphotericin B-deoxycholate in rats. Antimicrob Agents Chemother (2000) 0.79
A 3-year cohort study on short-term effects of air pollution in Germany. 1. Influences of medication and season. Sci Total Environ (1992) 0.79
[First observations using the scanning electron microscope in the early phase of endotoxin effect on terminal blood vessels]. Klin Wochenschr (1969) 0.79
UDP-Glucose: Cyanidin 3-O-glucosyltransferase from cell cultures of Haplopappus gracilis. Planta (1976) 0.79
Length of resting period between stimulation cycles modulates hemodynamic response to a motor stimulus. Adv Exp Med Biol (1997) 0.78
Radiological signs of Leri-Weill dyschondrosteosis in Turner syndrome. Horm Res (2001) 0.78
The different growth zones of the fetal foot. Ann Anat (2001) 0.78
Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT). Eur J Med Res (2009) 0.77
[Progress in diagnostics of anorectal disorders. Part I: anatomic background and clinical and neurologic procedures]. Chirurg (2008) 0.76
[The surgical anatomy of the genital nerves of the male and their preservation in excision of the rectum]. Chirurg (1989) 0.76
Pharmacokinetics and pharmacodynamics of penbutolol in healthy and cancer subjects: role of altered protein binding. Res Commun Mol Pathol Pharmacol (1996) 0.75
Effect of the muscarinic agonist carbachol on pial arteries in vivo after endothelial damage by air embolism. J Cereb Blood Flow Metab (1987) 0.75
Construction of a novel bifunctional biogenic amine receptor by two point mutations of the H2-histamine receptor. Mol Med (1995) 0.75
[Experimental decompression sickness in rabbits. Coagulation changes and therapeutic influencing]. Verh Dtsch Ges Inn Med (1971) 0.75
[Dose and time-saving fluoroscopy by means of immediate reproduction of a high-quality stored image (author's transl)]. Rontgenblatter (1979) 0.75
[Effect of endotoxin and histamine on the isolated frog skin]. Naturwissenschaften (1969) 0.75
[Evaluation of rheumatic activity in acquired heart diseases by quantitative plasma protein determination]. Schweiz Med Wochenschr (1970) 0.75
Simultaneous determination of tramadol and its major active metabolite O-demethyltramadol by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl (1999) 0.75
[Model of an ascending urinary tract infection]. Arch Hyg Bakteriol (1970) 0.75
Resistance to atracurium in rats with experimental inflammation: role of protein binding. Acta Anaesthesiol Scand (1995) 0.75
Use of achiral/chiral SFC/MS for the profiling of isomeric cinnamonitrile/hydrocinnamonitrile products in chiral drug synthesis. Anal Chem (2006) 0.75
[Immunological studies on the postcardiotomy syndrome]. Verh Dtsch Ges Inn Med (1968) 0.75
[Electronmicroscopical, functional morphological, morphometric analysis of anterior pituitary of Xenopus leavis (Anura)]. Verh Anat Ges (1976) 0.75
[Suffocating peroperative pneumothorax]. Cah Anesthesiol (1986) 0.75
[A simple device combination for the rapid and reliable determination of residual volume]. Dtsch Gesundheitsw (1978) 0.75
Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer. Cancer Chemother Pharmacol (1998) 0.75
Suspect older adult abuse and/or neglect? Tar Heel Nurse (2002) 0.75
[Effects of benzydamine on leukocyte aggregation]. Arzneimittelforschung (1987) 0.75
[Urine as culture medium for bacteria]. Arch Hyg Bakteriol (1970) 0.75
Cutaneous ligaments of the human hand. Eur J Morphol (1990) 0.75
[On the production of endotoxin tolerance by detoxified endotoxin (endotoxoid) in humans]. Verh Dtsch Ges Inn Med (1968) 0.75
[Paul Busse Grawitz and the processes of inflammation]. Med Klin (1965) 0.75
Long term toxicity studies with endotoxoid in monkeys. Experientia (1971) 0.75
[Jaundice after ovulation inhibiting steroids]. Med Klin (1969) 0.75
[Postpartum aortic rupture in coarctatio aortae]. Med Klin (1966) 0.75
Purified contact activation product of the coagulation system in experimental thrombosis. Atherosclerosis (1971) 0.75
[Pathologic-anatomical studies on scalariform sclerosis of the basilary arteries]. Z Kreislaufforsch (1966) 0.75
[Cholestatic jaundice following ovulation inhibitors]. Geburtshilfe Frauenheilkd (1969) 0.75
[Acute leukemia in the terminal phase of Hodgkin's disease: a consequence of the depressed immune function?]. Med Klin (1975) 0.75
[Serum transaminases and serum zinc in dietetic induced liver cirrhosis of the rat--observations of the course]. Acta Hepatosplenol (1971) 0.75
CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy. CPT Pharmacometrics Syst Pharmacol (2017) 0.75
[Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)]. Med Klin (1974) 0.75
[Enzymologic and cytochemical studies on tear-and blood cells in man and rabbit. (A contribution to the origin of inflammation leukocytes in the eye)]. Beitr Pathol Anat (1965) 0.75
Effect of epsilon-aminocaproic acid and beta-aminopropionitrile on the nutritional atheromatosis of the rabbit. J Atheroscler Res (1968) 0.75
[Immunofluorescent histological demonstration of the antigenic gastric mucosal esterase VIA in the superficial epithelium of human fundic gastric mucosa]. Z Gesamte Exp Med (1970) 0.75
[Parietal fibroplastic endocarditis and generalized endangiitis following chronic suppuration]. Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed (1965) 0.75
[On the effect of endotoxin on a biologic membrane (isolated frog skin) and its modification by drugs]. Verh Dtsch Ges Inn Med (1968) 0.75
[On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)]. Med Klin (1969) 0.75
[Feeding trials with epsilon-aminocaproic acid in animal experiments and its effect on the vascular system]. Z Gesamte Exp Med (1966) 0.75